Skip to main content
Premium Trial:

Request an Annual Quote

Deltagen Raises $22.5 M For Functional Genomics



ENLO PARK, Calif.--Deltagen announced that it has completed a $22.5 million round of financing that was led by Boston Millennia Partners and included investments by the Sprout Group, Baccharis Capital, Crossroads, and Lombard Odier & Cie. The proceeds of the offering will enable the company to advance several new drug target discovery programs as well as finalize and fully commercialize its DeltaBase product, a database with information about mammalian genes specifically relevant to small molecule drug discovery.

Filed under

The Scan

Rise of BA.5

The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government, CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.

Genome Research Papers on Craniosynostosis, Macaque Retrotransposition, More

In Genome Research this week: structural variants in craniosynostosis, LINE-1 activity in rhesus macaque brain, and more.